Novartis signs fresh deal to lend a hand originate Pfizer/BioNTech vaccine
Swiss prescription medication enormous Novartis said Thursday it has signed a fresh agreement to farm out about a of its manufacturing products and services and lend a hand perform necessary-wanted doses of the Pfizer-BioNTech coronavirus vaccine.
Novartis has been using its manufacturing facility in Stein in Switzerland to originate bigger than 50 million doses this year of the mRNA COVID-19 vaccine developed by German startup BioNTech and US drugmaker Pfizer.
The Pfizer-BioNTech vaccine is indubitably one of a handful which had been popular around the sphere in the global fight against the coronavirus pandemic.
In an announcement on Thursday, Novartis said it will now “exercise its sterile manufacturing products and services… in Ljubljana, Slovenia, to trust no longer lower than 24 million doses in 2022.”
The monetary phrases of the agreement were no longer disclosed.
Novartis said it will “put off bulk mRNA energetic ingredient from BioNTech and trust this into vials below sterile stipulations for shipment lend a hand to BioNTech for its distribution.”
© 2021 AFP
Quotation:
Novartis signs fresh deal to lend a hand originate Pfizer/BioNTech vaccine (2021, October 21)
retrieved 21 October 2021
from https://medicalxpress.com/recordsdata/2021-10-novartis-pfizerbiontech-vaccine.html
This myth is enviornment to copyright. As opposed to any magnificent dealing for the aim of non-public peek or learn, no
part will possible be reproduced with out the written permission. The protest material is provided for recordsdata applications easiest.